This inventor holds 4 USPTO granted patents. Top assignees: Novartis Ag, Schering Aktiengesellschaft, Other. Active years: 2002-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 3,978 
3 out of 1,409 
1 out of 834,570 Years Active: 2002-2006
Title: Inventor Spotlight: Stefano Ferrari
Introduction
Stefano Ferrari, an innovative inventor based in Muttenz, Switzerland, has made significant contributions to the field of medicinal chemistry. With a total of four patents to his name, his work focuses on developing new therapeutic agents aimed at treating diseases related to angiogenesis and neoplastic conditions.
Latest Patents
Ferrari's recent patents showcase his dedication to addressing complex health issues. One of his notable inventions, "Anthranilic acid amides and the use thereof as medicaments," pertains to the use of anthranilic acid amides in treating diseases triggered by persistent angiogenesis. This patent also covers intermediate products necessary for the production of these amides. Another significant patent involves "N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF." The compounds described can be beneficial for treating neoplastic diseases, retinopathy, and age-related macular degeneration by inhibiting VEGF receptor tyrosine kinase activity.
Career Highlights
Throughout his career, Stefano Ferrari has worked for prominent pharmaceutical companies, including Schering Aktiengesellschaft and Novartis AG. His experiences in these organizations have bolstered his expertise in drug development and innovation, playing an essential role in his successful patent applications.
Collaborations
Collaborative efforts have been significant in Ferrari's journey. He has worked alongside notable professionals such as Andreas Huth and Dieter Seidelmann, combining their expertise to enhance research outcomes and drive forward the development of novel medicinal products.
Conclusion
Stefano Ferrari exemplifies the pioneering spirit of innovation in medicinal chemistry. With a dedicated focus on addressing serious health conditions through his patented inventions, he continues to contribute valuable knowledge and solutions to the medical field. His work stands as a testament to the importance of collaboration and innovation in advancing healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile